CMS Updates Ventricular Assist Device Coverage Policy: What Billing Teams Need to Know (NCD 360)

The Centers for Medicare & Medicaid Services has modified its National Coverage Determination for ventricular assist devices (VADs) under NCD 360. This update refines the clinical criteria governing when Medicare will cover VAD implantation—including both bridge-to-transplant and destination therapy indications—and tightens the facility and multidisciplinary team requirements that must be in place before a claim will be considered payable. If your facility implants LVADs or manages post-cardiotomy VAD patients, this policy directly affects your coverage eligibility, prior authorization documentation, and credentialing compliance.

Field	Detail
Payer	Centers for Medicare & Medicaid Services (CMS)
Policy	Ventricular Assist Devices
Policy Code	NCD 360
Change Type	Modified
Effective Date	2026-03-12
Impact Level	High
Specialties Affected	Cardiothoracic Surgery, Advanced Heart Failure Cardiology, Cardiac Surgery, Palliative Care, Transplant Programs
Key Action	Verify your facility holds current CMS-approved credentialing and that your multidisciplinary VAD team meets every staffing requirement before scheduling any LVAD implant on a Medicare beneficiary.

---

What Changed in CMS NCD 360 for Ventricular Assist Devices

The modified NCD 360 (policy key 360-v2, effective March 12, 2026) maintains the core coverage framework for VADs while reinforcing and clarifying the conditions under which Medicare will pay. The policy continues to cover two primary categories: post-cardiotomy VAD support and LVAD therapy for advanced heart failure patients. However, the clinical eligibility criteria for LVADs are explicitly detailed, and the requirements around multidisciplinary team composition and facility credentialing carry more specificity than prior versions.

This matters for revenue cycle because a claim denied on the basis of medical necessity—or a facility failing a credentialing audit—cannot simply be re-billed. The documentation burden starts before the patient enters the operating room.

---

CMS LVAD Coverage Criteria: Medical Necessity Requirements Under NCD 360

For Medicare to cover an LVAD under NCD 360, the beneficiary must have all three of the following:

#	Covered Indication Copy
1	New York Heart Association (NYHA) Class IV heart failure
2	Left ventricular ejection fraction (LVEF) ≤ 25%
3	Inotrope dependence, OR a Cardiac Index (CI) < 2.2 L/min/m² while not on inotropes

If the patient meets the CI threshold rather than the inotrope-dependence threshold, they must also satisfy one of these additional conditions:

#	Covered Indication Copy
1	On optimal medical management (OMM) per current heart failure practice guidelines for at least 45 of the last 60 days and failing to respond; or
2	Advanced heart failure for at least 14 days and dependent on an intra-aortic balloon pump (IABP) or comparable temporary mechanical circulatory support for at least 7 days.

These are hard clinical thresholds—not soft indicators. Your clinical documentation must explicitly establish NYHA Class IV status, include a dated LVEF measurement, and clearly record inotrope status or CI measurement. If the medical record cannot support each criterion, the claim is at risk regardless of the implanting physician's clinical judgment.

---

Post-Cardiotomy VAD Coverage Under CMS NCD 360

VADs used to support circulation after open-heart surgery (the post-cardiotomy period) have been nationally covered since October 18, 1993. Coverage here is conditioned on two requirements:

1. The device must hold FDA approval specifically for post-cardiotomy use.
2. The VAD must be used strictly according to FDA-approved labeling instructions.

Off-label use in the post-cardiotomy setting is not covered under NCD 360. If your team is using a device for a post-cardiotomy indication not listed in the FDA labeling, that case would fall into the non-covered category unless it qualifies under a Category B investigational device exemption (IDE) clinical trial.

---

What CMS Does Not Cover: Non-Covered VAD Indications

The policy is direct: all VAD indications not explicitly listed as nationally covered remain non-covered. The only pathway to potential reimbursement for a non-listed indication is through a Category B IDE clinical trial under 42 CFR 405, or as a routine cost in a qualifying clinical trial under section 310.1 of the National Coverage Determination framework.

Billing teams should flag any VAD case that doesn't fit neatly into either the post-cardiotomy or LVAD heart failure categories. Those cases require coordination with your compliance and research billing teams before a claim is submitted.

---

Multidisciplinary Team Requirements CMS Now Requires for LVAD Coverage

This is where many facilities may find compliance gaps. CMS requires that every beneficiary receiving a VAD be managed by a cohesive, explicitly identified, multidisciplinary team. This is not a suggestion—it is a coverage condition.

At minimum, the team must include:

Role	Requirement
Cardiothoracic Surgeon	Surgical privileges + individual experience implanting at least 10 durable, intracorporeal LVADs in the prior 36 months, with activity in the last year
Advanced Heart Failure Cardiologist	Clinical competence in medical- and device-based management, including pre- and post-VAD patient management
VAD Program Coordinator	Based at the facility
Social Worker	Based at the facility
Palliative Care Specialist	Based at the facility

All team members must be facility-based—not consultants or telemedicine staff checking in remotely. The team must also ensure patients and caregivers can participate in genuine informed decision making.

If your cardiothoracic surgeon has not implanted 10 durable, intracorporeal LVADs in the past 36 months—or has had no LVAD activity in the past year—your facility does not currently meet this standard for that provider.

---

CMS Facility Credentialing Requirements for LVAD Destination Therapy

Facilities must hold credentialing from a CMS-approved credentialing organization. This isn't internal hospital credentialing—it's external certification by an organization that CMS has specifically approved for this purpose.

CMS maintains a public list of approved credentialing organizations, approved standard versions, and credentialed facilities at:
cms.gov/Medicare/Medicare-General-Information/MedicareApprovedFacilitie/VAD-Destination-Therapy-Facilities.html

Before you schedule a Medicare LVAD case, confirm your facility appears on that list. If your credentialing has lapsed or your organization hasn't been re-approved under the current standard, you are implanting without Medicare coverage eligibility—and that's a significant compliance and financial exposure.

---

Affected Codes

The Centers for Medicare & Medicaid Services did not list specific CPT or HCPCS codes in the published NCD 360 policy document. Revenue cycle teams should work with their coding staff to identify the applicable procedure codes for VAD implantation, post-cardiotomy support, and associated services under your encoder and crosswalk tools. Payer-specific coverage determinations at the MAC level may provide additional code-level guidance.

---

What Your Billing Team Should Do

Copy Action Items

---